BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15810957)

  • 1. Morphometric analysis of primary graft non-function in liver transplantation.
    Vertemati M; Sabatella G; Minola E; Gambacorta M; Goffredi M; Vizzotto L
    Histopathology; 2005 Apr; 46(4):451-9. PubMed ID: 15810957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extent of vacuolation in non-heart-beating porcine donor liver grafts prior to transplantation predicts their viability.
    Monbaliu D; Libbrecht L; De Vos R; Vekemans K; Walter H; Liu Q; Heedfeld V; Goossens V; Pirenne J; Roskams T
    Liver Transpl; 2008 Sep; 14(9):1256-65. PubMed ID: 18756467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial hepatic microcirculation correlates with early graft function in human orthotopic liver transplantation.
    Puhl G; Schaser KD; Pust D; Köhler K; Vollmar B; Menger MD; Neuhaus P; Settmacher U
    Liver Transpl; 2005 May; 11(5):555-63. PubMed ID: 15838880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The delay of rearterialization after initial portal reperfusion in living donor liver transplantation significantly determines the development of microvascular graft dysfunction.
    Puhl G; Schaser KD; Pust D; Köhler K; Vollmar B; Menger MD; Neuhaus P; Settmacher U
    J Hepatol; 2004 Aug; 41(2):299-306. PubMed ID: 15288480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ultrastructural changes in liver allografts of patients experiencing primary nonfunction.
    Lawal A; Florman S; Fiel MI; Gordon R; Bromberg J; Schiano TD
    Transplant Proc; 2005 Dec; 37(10):4339-42. PubMed ID: 16387115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraoperative oxygen consumption and organ function in liver transplantation].
    Schwitalla S; Heres F; Röhl FW; Pfau G; Kessling C
    Anaesthesiol Reanim; 2001; 26(4):88-94. PubMed ID: 11552435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury.
    Bogetti D; Sankary HN; Jarzembowski TM; Manzelli A; Knight PS; Thielke J; Chejfec G; Cotler S; Oberholzer J; Testa G; Benedetti E
    Clin Transplant; 2005 Aug; 19(4):507-11. PubMed ID: 16008596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential and simultaneous revascularization in adult orthotopic piggyback liver transplantation.
    Polak WG; Miyamoto S; Nemes BA; Peeters PM; de Jong KP; Porte RJ; Slooff MJ
    Liver Transpl; 2005 Aug; 11(8):934-40. PubMed ID: 16035059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survival-based scoring-system for initial graft function following orthotopic liver transplantation.
    Heise M; Settmacher U; Pfitzmann R; Wünscher U; Müller AR; Jonas S; Neuhaus P
    Transpl Int; 2003 Nov; 16(11):794-800. PubMed ID: 12844216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience.
    Uemura T; Randall HB; Sanchez EQ; Ikegami T; Narasimhan G; McKenna GJ; Chinnakotla S; Levy MF; Goldstein RM; Klintmalm GB
    Liver Transpl; 2007 Feb; 13(2):227-33. PubMed ID: 17256780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity.
    Monbaliu D; Vekemans K; Hoekstra H; Vaahtera L; Libbrecht L; Derveaux K; Parkkinen J; Liu Q; Heedfeld V; Wylin T; Deckx H; Zeegers M; Balligand E; Buurman W; van Pelt J; Porte RJ; Pirenne J
    Ann Surg; 2009 Nov; 250(5):808-17. PubMed ID: 19826248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary nonfunction in liver transplantation: a single-center experience.
    Taner CB; Bathala V; Nguyen JH
    Transplant Proc; 2008 Dec; 40(10):3566-8. PubMed ID: 19100439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological changes after liver transplantation according to the presence or not of graft steatosis.
    Muscari F; Guinard JP; Foppa B; Trocard P; Danjoux M; Kamel MS; Duffas JP; Rostaing L; Fourtanier G; Suc B
    Transplant Proc; 2008 Dec; 40(10):3562-5. PubMed ID: 19100438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fatty acid-binding protein: an early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors.
    Monbaliu D; de Vries B; Crabbé T; van Heurn E; Verwaest C; Roskams T; Fevery J; Pirenne J; Buurman WA
    Transplant Proc; 2005; 37(1):413-6. PubMed ID: 15808662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine improves graft survival after experimental liver transplantation.
    Schemmer P; Liang R; Kincius M; Flechtenmacher C; Bunzendahl H; Gutt CN; Mehrabi A; Gebhard MM; Büchler MW; Kraus TW
    Liver Transpl; 2005 Aug; 11(8):950-9. PubMed ID: 16035074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary graft nonfunction and Kupffer cell activation after liver transplantation from non-heart-beating donors in pigs.
    Monbaliu D; van Pelt J; De Vos R; Greenwood J; Parkkinen J; Crabbé T; Zeegers M; Vekemans K; Pincemail J; Defraigne JO; Fevery J; Pirenne J
    Liver Transpl; 2007 Feb; 13(2):239-47. PubMed ID: 17256782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary dysfunction after liver transplantation. Is it possible to predict this complication?
    Moreno Sanz C; Jiménez Romero C; Moreno González E; García García I; Seoane González I; Loinaz Segurola C; García Ureña MA; González Chamorro A
    Rev Esp Enferm Dig; 1999 Jun; 91(6):401-19. PubMed ID: 10431089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute blood leukocyte reduction after liver reperfusion: a marker of ischemic injury.
    Ardizzone G; Stratta C; Valzan S; Crucitti M; Gallo M; Cerutti E
    Transplant Proc; 2006 May; 38(4):1076-7. PubMed ID: 16757269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.